Importantly, the effects of recurrent obesity on serum corticosterone, glucose, and insulin were reversed by daisaikoto, indicating that this medicine may prevent weight regain by lowering serum corticosterone. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.